[EN] HETEROARYL SUBSTITUTED SPIROCYCLIC SULFAMIDES FOR INHIBITION OF GAMMA SECRETASE [FR] SULFAMIDES SPIROCYCLIQUES SUBSTITUES PAR HETEROARYLE UTILISES COMME INHIBITEURS DE LA GAMMA-SECRETASE
[EN] BENZOSULFONYL COMPOUNDS<br/>[FR] COMPOSÉS DE BENZOSULFONYLE
申请人:VIVACE THERAPEUTICS INC
公开号:WO2019040380A1
公开(公告)日:2019-02-28
Provided herein are compounds and pharmaceutical compositions comprising said compounds that are useful for treating cancers. Specific cancers include those that are mediated by YAP/TAZ or those that are modulated by the interaction between YAP/TAZ and TEAD.
[EN] TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE THEREOF<br/>[FR] INHIBITEURS DE LA KINASE 1 RÉGULANT LE SIGNAL D'APOPTOSE CONTENANT DES TÉTRAZOLES ET LEURS MÉTHODES D'UTILISATION
申请人:ENANTA PHARM INC
公开号:WO2019213244A1
公开(公告)日:2019-11-07
The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts and esters thereof: (I) which inhibit the Apoptosis signal-regulating kinase 1 (ASK-l), which is associated with autoimmune disorders, neurodegenerative disorders, inflammatory diseases, chronic kidney disease, cardiovascular disease. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from ASK-l related disease. The invention also relates to methods of treating an ASK-l related disease in a subject by administering a pharmaceutical composition comprising the compounds of the present invention. The present invention specifically relates to methods of treating ASK-l associated with hepatic steatosis, including non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
[EN] PROTEIN SECRETION INHIBITORS<br/>[FR] INHIBITEURS DE LA SÉCRÉTION DE PROTÉINES
申请人:KEZAR LIFE SCIENCES
公开号:WO2022047347A1
公开(公告)日:2022-03-03
Provided herein are secretion inhibitors, such as inhibitors of Sec61 for example of Formula (I), methods for their preparation, related pharmaceutical compositions, and method for using the same.
Heteroaryl substituted spirocyclic sulfamides for inhibition of gamma secretase
申请人:Collins James Ian
公开号:US20060173054A1
公开(公告)日:2006-08-03
Compounds of formula I are disclosed:
in which X is a 5-membered heteroaryl ring and R is as defined herein. The compounds are inhibitors of the processing of APP by gamma-secretase, and hence are useful in the treatment or prevention of Alzheimer's disease.
Heteroaryl substituted spriocyclic sulfamides for inhibition of gamma secretase
申请人:Collins James Ian
公开号:US20050182109A1
公开(公告)日:2005-08-18
Compounds of formula I are disclosed: in which X is a 5-membered heteroaryl ring and R is as defined herein. The compounds are inhibitors of the processing of APP by gamma-secretase, and hence are useful in the treatment or prevention of Alzheimer's disease.